AMNEAL PHARMACEUTICALS, INC. (AMRX) /
The debt of AMNEAL PHARMACEUTICALS, INC. over the past 10 years
Chart AMNEAL PHARMACEUTICALS, INC.: liquid cash, total debt, net cash, fiscal 2016–2025 Open the chart →At the end of fiscal 2025, the latest fiscal year on file, AMNEAL PHARMACEUTICALS, INC. had liquid cash of $282.03M and total debt of $2.57B: net debt of $2.29B. It had more debt than liquid cash at all 8 year-ends shown. Total debt was highest at the end of fiscal 2021 ($2.75B) and lowest at the end of fiscal 2017 ($1.44B). No net cash figure is on file for fiscal 2020.
Year by year
| Fiscal year | Liquid cash | Total debt* | Net cash* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $282.03M | $2.57B | -$2.29B |
| 2024ended Dec 31, 2024 | $110.55M | $2.49B | -$2.38B |
| 2023ended Dec 31, 2023 | $91.54M | $2.64B | -$2.55B |
| 2022ended Dec 31, 2022 | $25.98M | $2.72B | -$2.7B |
| 2021ended Dec 31, 2021 | $247.79M | $2.75B | -$2.5B |
| 2020ended Dec 31, 2020 | — | — | — |
| 2019ended Dec 31, 2019 | $151.2M | $2.63B | -$2.48B |
| 2018ended Dec 31, 2018 | $213.39M | $2.65B | -$2.44B |
| 2017ended Dec 31, 2017 | $74.17M | $1.44B | -$1.37B |
| 2016ended Dec 31, 2016 | — | — | — |
Fiscal years as AMNEAL PHARMACEUTICALS, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on AMNEAL PHARMACEUTICALS, INC.
- The revenue of AMNEAL PHARMACEUTICALS, INC.
- The profitability of AMNEAL PHARMACEUTICALS, INC.
- The cash flow of AMNEAL PHARMACEUTICALS, INC.
- All of AMNEAL PHARMACEUTICALS, INC.'s financials, charted
Companies of a similar size
- PPCPILGRIM’S PRIDE CORPORATION
- FAFFIRST AMERICAN FINANCIAL CORPORATION
- ACTEnact Holdings, Inc.
- LADLithia Motors, Inc.
- UBSIUNITED BANKSHARES INC/WV
Not investment advice. This page shows what AMNEAL PHARMACEUTICALS, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.